$172.4 Million
Tourmaline Bio
Tourmaline Bio
Confidentially Marketed Follow-On Offering
Active Bookrunner
$1.0 Billion
Mr. Cooper Group Inc.
Mr. Cooper Group Inc.
Senior Notes
Active Bookrunner
$201.5 Million
New Amsterdam Pharma N.V.
New Amsterdam Pharma N.V.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$75.0 Million
Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$600.0 Million
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$200.0 Million
Praxis Precision Medicines
Praxis Precision Medicines, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$30.5 Million
Eagle Point Income Company Inc.
Eagle Point Income Company, Inc.
Series C Term Preferred
Active Bookrunner
$100.0 Million
Boundless Bio, Inc.
Boundless Bio, Inc.
Initial Public Offering
Active Bookrunner
$115.1 Million
Ocular
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$161.0 Million
Keros
Keros Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.